William John Scheessele, Chief Commercial Officer at Humacyte, Inc. ($HUMA), made one open market purchase of shares in the last year, totaling about $10,000. His latest buy occurred on April 14, 2025. Among nearly 5,000 insiders, this ranks 4,304th for purchase value, compared to an average of $1.5 million over 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 14, 2025 | Humacyte, Inc. | $HUMA | Scheessele William John | Chief Commercial Officer | P | Common Stock | 6493 | $1.54 | 22,018.0000 | 155,118,816 | 41.82% | 0.00% |
| Jan. 21, 2025 | Humacyte, Inc. | $HUMA | Scheessele William John | Chief Commercial Officer | A | Stock Options (right to buy) | 283101 | $0.00 | 283,101.0000 | 0 | 9999.99% | 0.00% |
| Dec. 8, 2023 | Humacyte, Inc. | $HUMA | Scheessele William John | Chief Commercial Officer | A | Stock Options (right to buy) | 276000 | $0.00 | 276,000.0000 | 0 | 9999.99% | 0.00% |